The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boston-based biopharma company ...
Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...
Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by approximately $61.38 million over the prior quarter. The change represents 0.31% of ...
Following the conference, Rapport plans to make the posters available on its company website. In other recent news, Rapport Therapeutics has priced an underwritten public offering of 9,615,385 shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results